Cargando…
Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury
STUDY DESIGN: Utilizing a complete transection spinal cord injury (SCI) model at the fourth thoracic vertebral level in adult rats, we evaluated whether blocking noxious stimuli below the injury diminishes abnormal somatic and autonomic motor reflexes, manifested in muscular spasticity and hypertens...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953609/ https://www.ncbi.nlm.nih.gov/pubmed/20514053 http://dx.doi.org/10.1038/sc.2010.67 |
_version_ | 1782187860029341696 |
---|---|
author | Rabchevsky, Alexander G. Patel, Samir P. Duale, Hanad Lyttle, Travis S. O’Dell, Christopher R. Kitzman, Patrick H. |
author_facet | Rabchevsky, Alexander G. Patel, Samir P. Duale, Hanad Lyttle, Travis S. O’Dell, Christopher R. Kitzman, Patrick H. |
author_sort | Rabchevsky, Alexander G. |
collection | PubMed |
description | STUDY DESIGN: Utilizing a complete transection spinal cord injury (SCI) model at the fourth thoracic vertebral level in adult rats, we evaluated whether blocking noxious stimuli below the injury diminishes abnormal somatic and autonomic motor reflexes, manifested in muscular spasticity and hypertensive autonomic dysreflexia, respectively. Gabapentin (GBP) is well-tolerated and currently used to manage neuropathic pain in the SCI population; evidence suggests it acts to decrease presynaptic glutamate release. Since clinical evidence indicates that GBP may suppress muscular spasticity in the chronic SCI population, we hypothesized that preventing neurotransmission of noxious stimuli with GBP eliminates a critical physiological link to these distinct, debilitating SCI-induced secondary impairments. OBJECTIVES: Behavioural assessments of tail muscle spasticity and mean arterial blood pressure responses to noxious somatic and/or visceral stimulation were used to test the effects of GBP on these abnormal reflexes. SETTING: Lexington, Kentucky METHODS: We employed femoral artery catheterization and radio-telemetric approaches to monitor blood pressure alterations in response to noxious colorectal distension (CRD) weeks after complete SCI. RESULTS: At 2-3 weeks post-SCI, acute GBP administration (50 mg/kg, i.p.) significantly attenuated both autonomic dysreflexia and tail spasticity induced by noxious stimuli compared to saline-treated cohorts. CONCLUSION: These results demonstrate, for the first time, that a single pharmacological intervention, GBP, can effectively attenuate the manifestation of both muscular spasticity and autonomic dysreflexia in response to noxious stimuli. |
format | Text |
id | pubmed-2953609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
record_format | MEDLINE/PubMed |
spelling | pubmed-29536092011-07-01 Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury Rabchevsky, Alexander G. Patel, Samir P. Duale, Hanad Lyttle, Travis S. O’Dell, Christopher R. Kitzman, Patrick H. Spinal Cord Article STUDY DESIGN: Utilizing a complete transection spinal cord injury (SCI) model at the fourth thoracic vertebral level in adult rats, we evaluated whether blocking noxious stimuli below the injury diminishes abnormal somatic and autonomic motor reflexes, manifested in muscular spasticity and hypertensive autonomic dysreflexia, respectively. Gabapentin (GBP) is well-tolerated and currently used to manage neuropathic pain in the SCI population; evidence suggests it acts to decrease presynaptic glutamate release. Since clinical evidence indicates that GBP may suppress muscular spasticity in the chronic SCI population, we hypothesized that preventing neurotransmission of noxious stimuli with GBP eliminates a critical physiological link to these distinct, debilitating SCI-induced secondary impairments. OBJECTIVES: Behavioural assessments of tail muscle spasticity and mean arterial blood pressure responses to noxious somatic and/or visceral stimulation were used to test the effects of GBP on these abnormal reflexes. SETTING: Lexington, Kentucky METHODS: We employed femoral artery catheterization and radio-telemetric approaches to monitor blood pressure alterations in response to noxious colorectal distension (CRD) weeks after complete SCI. RESULTS: At 2-3 weeks post-SCI, acute GBP administration (50 mg/kg, i.p.) significantly attenuated both autonomic dysreflexia and tail spasticity induced by noxious stimuli compared to saline-treated cohorts. CONCLUSION: These results demonstrate, for the first time, that a single pharmacological intervention, GBP, can effectively attenuate the manifestation of both muscular spasticity and autonomic dysreflexia in response to noxious stimuli. 2010-06-01 2011-01 /pmc/articles/PMC2953609/ /pubmed/20514053 http://dx.doi.org/10.1038/sc.2010.67 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Rabchevsky, Alexander G. Patel, Samir P. Duale, Hanad Lyttle, Travis S. O’Dell, Christopher R. Kitzman, Patrick H. Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title | Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title_full | Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title_fullStr | Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title_full_unstemmed | Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title_short | Gabapentin for Spasticity and Autonomic Dysreflexia after Severe Spinal Cord Injury |
title_sort | gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953609/ https://www.ncbi.nlm.nih.gov/pubmed/20514053 http://dx.doi.org/10.1038/sc.2010.67 |
work_keys_str_mv | AT rabchevskyalexanderg gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury AT patelsamirp gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury AT dualehanad gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury AT lyttletraviss gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury AT odellchristopherr gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury AT kitzmanpatrickh gabapentinforspasticityandautonomicdysreflexiaafterseverespinalcordinjury |